Zoetis Combines CFO and COO Roles Under Veteran Healthcare Executive
Event summary
- Zoetis appoints Jay Saccaro as Executive Vice President, CFO and COO effective August 17, 2026
- Saccaro joins from GE HealthCare where he served as VP and CFO since 2023
- Wetteny Joseph transitions to Special Advisor role until early 2027
- New position combines global finance leadership with oversight of manufacturing and supply operations
The big picture
This leadership change comes as Zoetis positions itself for its next wave of innovation-driven growth. The combined CFO/COO role suggests a strategic focus on tightly integrating financial strategy with operational execution, particularly in manufacturing and supply chain management. Saccaro's extensive experience at large healthcare companies like GE HealthCare and Baxter International brings proven expertise in post-spin transformations and margin improvement initiatives.
What we're watching
- Strategic Priorities
- How Saccaro's dual CFO/COO role will balance financial discipline with operational execution in Zoetis' growth phase.
- Operational Integration
- The pace at which Saccaro can strengthen global manufacturing and supply operations to enhance Zoetis' competitive edge.
- Investor Engagement
- Whether Saccaro's experience in capital allocation will lead to more aggressive R&D investment or margin-focused operational improvements.
Related topics